Prescribing Information
Prescribing Information
Angeliq® (drospirenone and estradiol)
ANGELIQ 0.25 mg drospirenone (DRSP)/0.5 mg estradiol (E2) is an estrogen/progestin indicated in women with an intact uterus for the treatment of vasomotor symptoms due to menopause.
ANGELIQ 0.5 mg DRSP/1 mg E2 is an estrogen/progestin indicated in women with an intact uterus for the treatment of vasomotor symptoms due to menopause and vulvar and vaginal atrophy symptoms due to menopause.
Climara® (estradiol) transdermal patch
CLIMARA is an estrogen indicated for treatment of moderate to severe vasomotor symptoms due to menopause and treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause. When prescribing solely for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause, first consider the use of topical vaginal products. Also indicated for the treatment of hypoestrogenism due to hypogonadism, castration or primary ovarian failure and prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis, first consider the use of non-estrogen medications. Consider estrogen therapy only for women at significant risk of osteoporosis.
Climara Pro® (estradiol/levonorgestrel) transdermal patch
CLIMARA PRO is an estrogen plus progestin indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause and prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis, first consider the use of non-estrogen medications. Consider estrogen therapy only for women at significant risk of osteoporosis.
Menostar® (estradiol) transdermal patch
MENOSTAR is an estrogen indicated for prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal osteoporosis, first consider the use of non-estrogen medications. Consider estrogen therapy only for women at significant risk of osteoporosis.
Mirena® (levonorgestrel-releasing intrauterine system)
MIRENA is a progestin-containing intrauterine system (IUS) indicated for prevention of pregnancy for up to 8 years, and treatment of heavy menstrual bleeding for women who choose to use intrauterine contraception as their method of contraception for up to 5 years.
Kyleena® (levonorgestrel-releasing intrauterine system)
KYLEENA is a progestin-containing intrauterine system (IUS) indicated for prevention of pregnancy for up to 5 years.
Skyla® (levonorgestrel-releasing intrauterine system)
SKYLA is a progestin-containing intrauterine system (IUS) indicated for prevention of pregnancy for up to 3 years.
Yasmin® (drospirenone/ethinyl estradiol) tablets
YASMIN is an estrogen/progestin combination oral contraceptive (COC) indicated for use by women to prevent pregnancy.
Safyral® (drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium) tablets
SAFYRAL is an estrogen/progestin COC containing a folate, indicated for use by women to prevent pregnancy, and raise folate levels in women who choose to use an oral contraceptive for contraception.
Yaz® (drospirenone/ethinyl estradiol) tablets
YAZ is an estrogen/progestin COC, indicated for use by women to prevent pregnancy, treat symptoms of premenstrual dysphoric disorder (PMDD) for women and who choose to use an oral contraceptive for contraception, and treat moderate acne for women at least 14 years old only if the patient desires an oral contraceptive for birth control.
BeYaz® (drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium)
BEYAZ is an estrogen/progestin COC containing a folate, indicated for use by women to prevent pregnancy, treat symptoms of premenstrual dysphoric disorder (PMDD) for women who choose to use an oral contraceptive for contraception, treat moderate acne for women at least 14 years old only if the patient desires an oral contraceptive for birth control, and raise folate levels in women who choose to use an oral contraceptive for contraception.
Natazia® (estradiol valerate and estradiol valerate/dienogest) tablets
NATAZIA is an estrogen/progestin COC, indicated for use by women to prevent pregnancy. The efficacy of NATAZIA in women with a body mass index (BMI) of >30 kg/m2 has not been evaluated. Also indicated for treatment of heavy menstrual bleeding in women without organic pathology who choose to use an oral contraceptive as their method of contraception.
Yaz® (drospirenone/ethinyl estradiol) tablets
YAZ is an estrogen/progestin COC, indicated for use by women to prevent pregnancy, treat symptoms of premenstrual dysphoric disorder (PMDD) for women and who choose to use an oral contraceptive for contraception, and treat moderate acne for women at least 14 years old only if the patient desires an oral contraceptive for birth control.
BeYaz® (drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium)
BEYAZ is an estrogen/progestin COC containing a folate, indicated for use by women to prevent pregnancy, treat symptoms of premenstrual dysphoric disorder (PMDD) for women who choose to use an oral contraceptive for contraception, treat moderate acne for women at least 14 years old only if the patient desires an oral contraceptive for birth control, and raise folate levels in women who choose to use an oral contraceptive for contraception.
Safyral® (drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium) tablets
SAFYRAL is an estrogen/progestin COC containing a folate, indicated for use by women to prevent pregnancy, and raise folate levels in women who choose to use an oral contraceptive for contraception.
BeYaz® (drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium)
BEYAZ is an estrogen/progestin COC containing a folate, indicated for use by women to prevent pregnancy, treat symptoms of premenstrual dysphoric disorder (PMDD) for women who choose to use an oral contraceptive for contraception, treat moderate acne for women at least 14 years old only if the patient desires an oral contraceptive for birth control, and raise folate levels in women who choose to use an oral contraceptive for contraception.
Mirena® (levonorgestrel-releasing intrauterine system)
MIRENA is a progestin-containing intrauterine system (IUS) indicated for prevention of pregnancy for up to 8 years, and treatment of heavy menstrual bleeding for women who choose to use intrauterine contraception as their method of contraception for up to 5 years.
Natazia® (estradiol valerate and estradiol valerate/dienogest) tablets
NATAZIA is an estrogen/progestin COC, indicated for use by women to prevent pregnancy. The efficacy of NATAZIA in women with a body mass index (BMI) of >30 kg/m2 has not been evaluated. Also indicated for treatment of heavy menstrual bleeding in women without organic pathology who choose to use an oral contraceptive as their method of contraception.
Follow Us
